Company Presentation
Download our Company PresentationMay 2018
News View all news
Evotec expands iPSC platform with licence from ID Pharma
Hamburg, Germany, 23 May 2018
Evotec AG today announced that it has expanded its iPSC platform through a licence agreement with ID Pharma. The non-exclusive licence enables Evotec to both work with and differentiate induced pluripotent stem cells (“iPSC”) produced with ID Pharma’s Sendai virus (“SeV”) vector technology.
Read moreBusiness Dev Events View all events
4 June2018
7 June2018
2018 BIO International Convention
Venue: Boston, USA
Organisers: Biotechnology Innovation Organization (BIO)
6 June2018
8 June2018
19th Annual Drug Discovery Summit
Venue: Berlin, Germany
Organisers: Oxford Global Marketing
Investor Relations Events View all events
5 June2018
6 June2018
Jefferies 2018 Global Healthcare Conference
Venue: New York City, USA
Organisers: Jefferies
7 June2018
dbAccess Berlin Conference
Venue: Berlin, Germany
Organisers: Deutsche Bank
